Market Research Blog

According to Future Market Insights, the pharmaceutical filtration market is expected to record a robust CAGR of 6.1% for the period from 2017 to 2022.

Active pharmaceutical ingredients are a key component of the pharmaceutical industry in the 21^st century. Filters are essential in a number of cases during the course of API creation and are necessary in bioscience laboratory applications as well. An increased production of large biologics and molecules, nano fibre technological advancements, generic market growth, and regulatory guidelines for cleanroom pharmaceutical production are the main factors driving the pharmaceutical filtration market. Additional funds diverted towards R&D expenditure by major biopharmaceutical organizations also boost the profile of the pharmaceutical filtration market

• Manufacturing has the major portion of the revenue share in the pharmaceutical filtration market by operation in 2017 and is likely to remain so throughout the duration of the forecast period. The manufacturing segment is expected to cross a value of more than US$ 9.3 billion by end 2022 making it imperative for companies to be present in this operation segment of the pharmaceutical filtration market. The pilot scale segment follows at a considerable distance but cannot be overlooked entirely in favour of manufacturing. The pilot scale filtration segment has strong scope in North America as the continent represents a little over a third of the pharmaceutical filtration market and is estimated to retain this share going forward

• The cell separation segment comprises slightly above a sixth of the pharmaceutical filtration market by application and is predicted to lose popularity in the future. Nonetheless, the North America cell separation market alone is on track to push past a billion dollars by end 2022 and companies are advised to take this into account while devising their business strategies. The water purification segment has a similar revenue share to the cell separation segment in the pharmaceutical filtration market by application. After North America, the water purification segment is particularly prominent in Europe
• In terms of technology, microfiltration is quite popular as it contributes nearly half the revenue share in the pharmaceutical filtration market in the year 2017. Furthermore, microfiltration is anticipated to witness a high CAGR of more than 5.5% for the period 2017-2022 ensuring that all key stakeholders have ample opportunity in this lucrative technology. Ultrafiltration is not as prominent as microfiltration in the pharmaceutical filtration market but is gaining traction recently. Ultrafiltration technology has the greatest scope in both North America and Europe as these two continents are projected to cross a billion dollars in terms of value by end 2022
• North America is the largest region in the pharmaceutical filtration market and is poised to grow to more than US$ 6 billion by end 2022
• The report has profiled a few of the companies in the pharmaceutical filtration market. These include The Marmon Group LLC, Sartorius Stedim Biotech, Meissner Filtration Products, Parker Hannifin Corporation, Pall Corporation, Merck KGaA, GE Healthcare Inc., Eaton Corporation Plc., Amazon Filters Ltd., and 3M Companies.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/sample/rep-gb-5028

Key Segments:

Pharmaceutical Filtration Market Taxonomy

Region

• North America
• Latin America
• Europe
• Japan
• APEJ
• MEA

Product Type

• Membrane Filters
• Prefilters and Depth Media Filters
• Single-use Systems
• Cartridge & Capsule Filters
• Filter Holders
• Filtration Accessories
• Other Products

Scale of Operation

• Manufacturing Scale
• Pilot Scale
• R&D Scale
• Application
• Final Product Processing
• Raw Material Filtration
• Cell Separation
• Water Purification
• Air Purification

Technology

• Microfiltration
• Ultrafiltration
• Nanofiltration
• Other techniques

Inquire Before Buying This Research Report:

https://www.futuremarketinsights.com/ask-question/rep-gb-5028

About Us    

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

FMI, an ESOMAR-certified market research firm, estimates global contrast media injectors market revenues to reach US$ 1.5 Bn in 2022. In its new study, FMI takes a long-term optimistic view of the market, estimating global revenues to grow at 6.2% CAGR through 2030. The report opines that AI’s growing penetration in the healthcare sector will also rub off on contrast media injectors industry during the next decade.

Key Takeaways of Contrast Media Injectors Market Study

• North America is expected to be the most lucrative region and account for more than 32% of revenue in the global contrast media injectors in 2022 and this trend is expected to continue during the forecast period
• Larger patient pool and increasing government support towards developing healthcare system in Asian countries are expected to propel the growth of the contrast media injectors market in the region
• AI is expected to speed up the process of injecting contrast media in the forecast period
• Increasing applications in orthopedic surgeries and neurosurgeries to bolster the market in the forecast period

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/sample/rep-gb-823

New Product Launches and Approval – The Ongoing Trend

The market players are into getting their new products launched as well as approved to stay in the competition and also keep pace with the market scenario (that of continuing to innovate). The constructive steps in this regard are:

• In Apr 2022, Guerbet announced getting approved by the US FDA for manufacturing gadoterate meglumine (Dotarem) injection inside the US. Till late 2019, this production used to happen outside of the US.
• In Nov 2021, the US FDA approved an MRI contrast agent “Clariscan” for intravenous use in spine, brain (intracranial), and associated tissues.
• In Aug 2021, Bracco Diagnostics, Inc. announced getting approved by the US FDA for oral suspension of barium sulfate (Varibar Thin Liquid). The basic use of this contrast agent is detection and assessment of dysphagia.

What else is in the report?

Future market insights offer actionable insights and unique perspective on contrast media injectors market in its latest study, presenting historical demand assessment from 2014 – 2021 and projections from 2022–2030 based on product type (angiographic injectors, magnetic resonance imaging (MRI) injectors, computed tomography (CT) injectors), by end-user (hospital, ambulatory surgical centres, diagnostics centres) in seven key regions

Competitive Landscape

Companies operating in the contrast media injectors market are competitive by nature, with a presence of few players. These players are involved in a number of strategic alliances.

The contrast media injector’s market players are trying out every possible mode of organic/inorganic growth to sustain themselves in the market. The product launch and acquisition accelerates the manufacturer’s strategy to capitalize on the market share and capture the significant share of market.

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
  • Detailed insights of market segments and sub-segments for historical as well as forecast period
  • A competitive analysis of prominent players and emerging players in the keyword market
  • Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

Inquire Before Buying Research Report:

https://www.futuremarketinsights.com/ask-question/rep-gb-823

About Us    

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

The mentioned figures, coupled with an influx of ophthalmic diagnostic centres in the countries like India and China (homes to the 2 top-seeded diabetic patients) are expected to drive the ophthalmic diagnostic equipment market in the forecast period. As per NCBI, the number of people suffering from diabetic retinopathy will increase from 126.6 Mn in 2010 to 191 Mn by 2030. It also states that VTDR (Vision-threatening Diabetic Retinopathy) will witness an increase from 37.3 Mn to 56.3 Mn in the same period.

Plus, the reimbursement scenario regarding eye care treatment is improving in developed and developing countries alike. Initially, reimbursement was possible only if there was a hospital stay for at least 24 hours.

However, the present scenario is such that LASER technology enables single-day treatment and insurance coverage is applicable therein. So, people in low-income countries will also not shy away from availing eye care treatments.

Key Takeaways of Ophthalmic Diagnostic Equipment Market Study

• The optical coherence tomography (OCT) held the largest share in the global ophthalmic diagnostic equipment market in 2021
• North America and Europe are expected to hold close to 30% of the global ophthalmic diagnostic equipment market in 2022 and the trend is expected to continue In the forecast period
• Asia Pacific expected to witness an exponential growth in the forecast period

Expansion and Visibility: Indigenous Strategies for Market Players

The ophthalmic diagnostic equipment market players are focusing on qualitative expansion and visibility to sustain their foothold in the ophthalmic diagnostic equipment market. Some of the steps taken on this count include:

• In June 2022, IBM Watson partnered with Japan-based Topcon Corporation in order to fast-track the development of products and services that improve the diagnosis, and treatment of eye disease, ultimately improving access for better patient care.
• In June 2022, Essilor collaborated with Michelin for jointly launching an UN-certified awareness campaign named “Together for safe mobility: Check your vision, check your tires”. The basic objective is to throw light on good vision apart from good tires. This campaign is likely to increase the demand for ophthalmic diagnostic equipment worldwide as UN has officially recommended road safety goals at a global level.
• Ellex is working in close collaboration with the ophthalmic physicians across the globe regarding minimally invasive options for treatment of glaucoma.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/sample/rep-gb-771

What else is in the report?

Future market insights offer a unique perspective and actionable insights on ophthalmic diagnostic equipment market in its latest study, presenting historical demand assessment from 2013 – 2021 and projections from 2022–2030 based on product type (Fundus Cameras, Retinal Ultrasound Imaging Systems, Refractors, Slit Lamps, Perimeters, Ophthalmoscopes, Tonometer, Optical Coherence Tomography (OCT), Corneal Topography Systems), by end user (Hospitals, Clinics, Ambulatory Surgical Centers) in seven key regions.

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
  • Detailed insights of market segments and sub-segments for historical as well as forecast period
  • A competitive analysis of prominent players and emerging players in the keyword market
  • Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

Ophthalmic Diagnostic Equipment Market by Category

By Product :

• Fundus Cameras
• Retinal Ultrasound Imaging Systems
• Refractors
• Slit Lamps
• Perimeters
• Ophthalmoscopes
• Tonometer
• Optical Coherence Tomography (OCT)
• Corneal Topography Systems

By End user :

• Hospitals
• Clinics
• Ambulatory Surgical Centers

By Region :

• North America
• Latin America
• Western Europe
• Eastern Europe
• AEJ
• Japan
• Middle East and Africa (MEA)

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-771

Table of Content

1. Research Methodology
2. Assumptions & Acronyms Used
3. Executive Summary
4. Global Ophthalmic Diagnostic Equipment Market Overview

4.1. Introduction

4.1.1. Taxonomy

4.1.2. Definition

4.1.3. Introduction & Parent Market Overview

4.1.4. Market Value Forecast, 2022–2030

4.1.5. Global Ophthalmic Diagnostic Equipment Market Snapshot

4.2. Global Ophthalmic Diagnostic Equipment Market Dynamics

4.2.1. Drivers

4.2.2. Restraints

4.3. Global Ophthalmic Diagnostic Equipment Market Trends

4.4. Global Ophthalmic Diagnostic Equipment Market – Scenario Forecast

4.5. Global Ophthalmic Diagnostic Equipment Market Pricing Analysis

4.5.1. Global Ophthalmic Diagnostic Equipment Market Price Estimates, By Region, 2022

4.5.2. Global Ophthalmic Diagnostic Equipment Market Price Estimates, By Region, 2030

Inquire Before Buying Research Report:

https://www.futuremarketinsights.com/ask-question/rep-gb-771

About Us    

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

According to a recent Future Market Insights (FMI) industry analysis, the demand in the high-end cellomics market is expected to top US$ 288.8 Mn in 2021, growing at a CAGR of 6.4% during the forecast period 2021-2031.

High-end cellomics is a process that is utilized in drug discovery and biological research to identify substances such as small molecules, RNAi or peptides which alter the phenotype of a cell in a wanted manner.

The global high-end cellomics market is primarily driven by increasing technological advancement in imaging solutions. Technological advancements such as the usage of polarization methods, multicolored fluorescence-based reagents, automated imaging technology, and flow cytometry are also anticipated to boost the market growth further.

Increasing investment in research and development in cellular science of novel molecules by private and government organizations, technological advancement in imaging solutions, and advantages related to these innovations such as improved scope for pplication in gene documentation & neonatal development learning will drive the high-end cellomics market.

Key Takeaways from High-end Cellomics Market Study

• The global high-end cellomics market is expected to reach US$ 536.9 Mn by 2031.
• By application, drug discovery accounted for 55.5% of overall sales in 2021 and is expected to continue to grow at the same trend during the forecast period.
• By end-users, pharmaceutical and biotechnology companies will account for the largest share of 51.8% during the forecast period.
• By region, North America held the largest share of 32.7% of the global high-end cellomics market.
• By country, the U.S. is the most lucrative market in the global high-end cellomics market with US$ 81.7 Mn revenue in 2021.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/sample/rep-gb-14164

Who is Winning?

Some of the leading manufacturers of high-end cellomics are focusing on product approvals and launch strategies for global expansion objectives, thereby, enhancing their market presence. The leading key players are focusing on strategic alliance to expand the product offerings.

Yokogawa Electronic Corporation in December 2020, agreed with InSphero AG to jointly promote the use of Yokogawa’s high-end cellomics systems for drug discovery research which actively involves the use of 3D in vitro models.

The key market players covered by FMI include PerkinElmer, Inc., ThermoFisher Scientific, Inc., Molecular Devices LLC (part of Danaher Corporation) and Yokogawa Electric Corporation.

About the Healthcare Division at Future Market Insights

Future Market Insights facilitates corporates, government, investors, and associated audiences in the healthcare sector to identify and accentuate vital aspects applicable to product strategy, regulatory landscape, technology evolution, and other crucial issues to achieve sustainable success. Our unique approach to gathering market intelligence equips you in devising innovation-driven trajectories for your business. Know more about our sector coverage here

High-end Cellomics Market by Category

Application:

• Academic Research/Basic Research
• Drug Discovery
  • Primary & Secondary Screening
  • Target Identification & Validation
  • Invitro Toxicity Studies
  • Compound Profiling

End-User:

• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Independent Contract Research Organizations (CROs)

Region:

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• The Middle East and Africa (MEA)

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-14164

Table of Content

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

2.3. Inclusion & Exclusion

3. Key Trends

3.1. Key Trends Impacting the Market

3.2. Trends in Diverse Application

4. Key Success Factors

4.1. Key Products USP Analysis

4.2. Key Manufacturers Promotional Strategies

4.3. Value Chain Analysis

4.4. PESTLE Analysis

4.5. PORTERS Analysis

4.6. Key Regulations

Inquire Before Buying Research Report:

https://www.futuremarketinsights.com/ask-question/rep-gb-14164

About Us    

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

[140 Pages Report] Consistent evaluation of cost-saving options such as regulatory affairs outsourcing is carried out by several drug/device manufacturers in order to streamline their operations and ensure product safety and maintain public healthcare.

The global health care regulatory affairs outsourcing market includes services like regulatory writing and publishing, clinical trial applications, etc. A new research report by Future Market Insights provides an in-depth analysis of the global  regulatory affairs outsourcing market. This comprehensive research report is titled ‘Healthcare Regulatory Affairs Outsourcing Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2022 – 2028’.

It includes all the crucial numbers of the market along with the dynamics impacting it. According to this research report the global healthcare regulatory affairs outsourcing market is expected to reach a market revenue of over US$ 2.54 Bn by the end of 2028, growing at a stellar CAGR of 13.5% over the forecast period. The growth of the market is triggered largely by the increasing investments in the healthcare industry along with the increase in research and developments taking place.

Request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-6355 

Also increasing focus on CMOs and CROs has been observed in the market. The reports also depicts that Asia Pacific is expected to lead the global healthcare regulatory affairs outsourcing market during 2022-2028. Low cost, fast turnaround time and easy availability of the skilled and trained professionals will further result in increased outsourcing in APAC countries.

Global Healthcare Regulatory Affairs Outsourcing Market:  Segmental Analysis

Based on End Users, mid-size pharmaceutical companies leads the market with a high market size expected during the forecast period, growing at a CAGR of 13.8% during the forecast period. However Biotechnology companies are also progressing at a high rate and is expected to give a strong competition to mid-size pharma companies in terms of growth rate expected during the forecast period.

On the basis of Services, regulatory writing and publishing service segment is expected to dominate the market with a market share of over US$ 800 Mn by the end of 2028. However the segment is much behind the other services in terms of growth rate. Regulatory consulting and legal representation is the service which is expected to register fastest growth at a CAGR of 14.3% during the forecast period.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-6355

In terms of Region, Asia Pacific is expected to be the largest region with a high market valuation. However, North America is also expected to give tough competition to APAC. Both these regions are expected to reflect a valuation higher than US$ 720 Mn by 2028 end. However North America lags behind in the race with comparatively less CAGR expected during the forecast period. Whereas, Asia Pacific is expected to register the fastest growth rate of 13.2% CAGR during the forecast period.

Preview Analysis on Healthcare Regulatory Affairs Outsourcing Market Segmentation By Services Type – Regulatory Writing and Publishing, Regulatory Submissions, Clinical Trial Applications, and Product Registrations, Regulatory Consulting and Legal Representation, Other Regulatory Affairs; By End Users Type – Mid-Size Pharmaceutical, Companies,Large Pharmaceutical Companies, Biotechnology Companies, Medical Devices Manufacturer, Food & Beverage

Global Healthcare Regulatory Affairs Outsourcing Market:  Competitive Landscape

The research report consists of a brief profile of all the major players leading in the industry. It also includes a SWOT analysis of these companies. The leading players mentioned in the report includes companies like Clinilabs, Inc., Accell Clinical Research, LLC.,  Freyr Solutions, The Weinberg Group Inc., Covance, Inc., (LabCorp), Pharmaceutical Product Development LLC, ICON plc., Sciformix Corporation etc.

For Information On The Research Approach Used In The Report, Request TOC@ https://www.futuremarketinsights.com/toc/rep-gb-6355 

Healthcare Regulatory Affairs Outsourcing Market by Category

Services:

• Regulatory Writing and Publishing
• Regulatory Submissions
• Clinical Trial Applications
• Product Registrations
• Regulatory Consulting and Legal Representation

End User:

• Mid-Size Pharmaceutical Companies
• Large Pharmaceutical Companies
• Biotechnology Companies
• Medical Devices Manufacturer
• Food & Beverage Companies

Region

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• Middle East & Africa

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 6-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

The Exosomes Diagnostic and Therapeutic Market is expected to be worth USD 58.6 million in 2022 and USD 175.4 million by 2028, expanding at a CAGR of 20.0 percent during the forecast period (2022-2028).

Market Outlook:

Data Points	Market Insights
Market Value 2021	US$ 46.7 Mn
Market Value 2028	US$ 175.4 Mn
CAGR 2022-2028	20.0%
Market Share of Top 5 Countries	75.3%

Future Market Insights in its recent research report titled “Exosome Diagnostic and Therapeutics Market: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2027)” covers several factors that are influencing the robust growth of the global market. As per this research report, the global exosome diagnostic and therapeutic market is projected to expand at a high CAGR of 23.1% during the period of assessment.

Request For Report Sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-6379

The exhaustive research publication includes key trends, opportunities, threats, growth drivers and challenges that impact the global exosome diagnostic and therapeutics market. Detailed pricing analysis of different exosome diagnostic and therapeutics across key regions is also discussed in the research study. The segmental analysis across North America, Western Europe, Eastern Europe, Asia Pacific excluding Japan (APEJ), Latin America, Japan and Middle East and Africa (MEA) is carried out which is used to track the future projections for a period of ten years, pertaining to value, of the global exosome diagnostic and therapeutics market.

Global Market for Exosome Diagnostic and Therapeutics: Underlying Forces Influencing Growth

The growth of global market for exosome diagnostics and therapeutics is influenced by several factors. Increasing need for screening and diagnosis of chronic diseases coupled with high therapeutic potential of exosomes are fuelling the adoption of exosome diagnostics and therapeutics. Moreover, introduction of explicit systems for analysis of proteins specific to exosomes, increasing research and development activities supported by favourable government policies across various regions and increasing popularity of exosome over CTC and ctDNA are expected to trigger the growth of the global market for exosome diagnostic and therapeutics market in the years to follow. On the contrary, lack of standardization and validation requirements for isolation of exosomes is expected to pose hindrances to the growth of the global market. Other factors negatively impacting the market’s growth include heavy investments in research and development and insufficient insurance coverage of costly cancer diagnostic tests.

Segmentation Highlights of the Global Exosome Diagnostic and Therapeutics Market

The global exosome diagnostic and therapeutics market is segmented on the basis of product type, application, end user and region.

In the region category, North America is estimated to be the largest with a high market lucrativeness. This region is expected to grow at a significant CAGR during the forecast period to touch a large market estimation by end of the assessment year, thus leading the global market. Moreover, Asia Pacific excluding Japan (APEJ) is the fastest growing region and is the second largest in terms of adoption and use of exosome diagnostics and therapeutics. APEJ is filled with high growth opportunities and is being targeted by several giants in this sector, such as Thermo Fisher Scientific.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-6379

By product type, reagents and kits are gaining high traction owing to increasing use in exosome diagnostics and therapeutics. The reagents and kits segment dominated the market in 2017 and is anticipated to continue with the trend in the coming years. This segment is also expected to expand at a high growth rate during the forecast period. The reagents and kits segment is expected to register a high CAGR of 28.2% throughout the period of forecast. The software segment is the second fastest growing segment spurring the growth of the global market.

In the application category, diagnostic segment is the largest as compared to therapeutics segment and is estimated to touch a value of over US$ 90 Mn by the end of the year of assessment, growing at a significant pace. Therapeutics segment is projected to expand at a CAGR of 29.0% throughout the period of assessment.

With respect to end user, the use of exosome diagnostic and therapeutics is largely observed in diagnostic centres. The diagnostic centres segment is expected to surpass other end user segments with a high market share and growth rate in the coming years.

Forecast Analysis of the Global Exosome Diagnostic and Therapeutics Market

According to the research report, the global market for exosome diagnostic and therapeutics is expected to grow at a high CAGR to reach an estimate of over US$ 150 Mn by the end of the year of assessment from a value of about US$ 19 Mn in 2017.

Competitive Landscape Shaping the Global Exosome Diagnostic and Therapeutics Market

Manufacturers of exosome diagnostic and therapeutics are focusing to raise capital required for launch of new products or research and development expenses through venture financing. Key companies such as

• Thermo Fisher Scientific Inc.
• NanoSomix Inc.
• NX PHARMAGEN
• Capricor Therapeutics Inc.
• Exosome Diagnostics Inc.
• Exiqon A/S (Aethlon Medical Inc.).
• System Biosciences Inc.
• Aegle Therapeutics AMS Biotechnology (Europe) Limited
• Miltenyi Biotec.

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-6379

Market segmentation

By Product Type

• • Instrument
• Software
• Reagents and Kits

By Application

• Diagnostics
• Therapeutics

By End User

• Hospitals
• Cancer Institutes
• Diagnostic Centres
• Others

By Region

• North America
• Latin America
• Eastern Europe
• Western Europe
• Asia Pacific excluding Japan
• Japan
• Middle East and Africa

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

 

[297 Pages Report] The global IoT in healthcare market is projected to reach US$ 181.4 Billion in 2022, anticipated to grow at a CAGR of 18.0%, reaching US$ 952.3 Billion by 2032. The market is slated to document a Y-o-Y growth rate of 20.7% from 2021-2022, increasing from the previously registered value of US$ 150.3 Billion.

By enabling real-time patient data access and remote patient monitoring, the Internet of Things (IoT) has the potential to disrupt traditional paper-based healthcare therapy. With the emergence of this digital healthcare technology, the impending need for enhanced diagnostics and targeted therapeutic options was met.

Furthermore, it not only enables physicians to remotely monitor patients, but it also functions as a fitness and wellness tracker for athletes and a dose reminder for patients. The successful implementation of IoT in remote monitoring of diabetic and asthma patients, along with the growing usage of fitness and wellness devices, has resulted in a considerable demand for the IoT healthcare business.

Download FREE Sample Copy of Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14639

Key Takeaways from the Market Study
•IoT in healthcare experienced a growth rate worth 18.8% between 2015 and 2021

•Portable diagnostic devices in the IoT in Healthcare segment to expand at a CAGR of 10.1% during the forecast period

•In the U.S., the market is predicted to reach US$ 208.1 Billion while growing at a CAGR of 18.9% during the forecast period

•China’s market is expected to reach a market value of US$ 92.8 Billion with a CAGR of 19.5% during the forecast period

“Big data analytics is an area of IoT that is quickly expanding. The most recent breakthroughs in machine learning, logical procedures, computational intelligence, and data mining are required for big data analytics”, says an FMI analyst.

Ask for Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-14639

Competitive Landscape

Key players that have been profiled in the report are Apple Inc., Cisco Systems Inc., GE Healthcare Ltd., Google (Alphabet), International Business Machines
Corporation, Medtronic PLC, Microsoft Corporation, Proteus Digital Health, Koninklijke Philips N.V., QUALCOMM Incorporated, and Abbot Laboratories are among companies that offer products and technologies that will allow customers to take advantage of new technologies.

•In April 2019, Royal Philips and Spencer Health Solutions expanded their relationship to provide chronically sick patients in selected European Union (EU) nations with in-home medication adherence and the Philips telehealth platform.

•Medtronic worked with IBM Watson in January 2019 to provide IQcast, a new feature of its current product Sugar.IQ, for iOS mobile devices in the United States. The software would provide patients with a hypoglycemic episode to monitor their low glucose level by anticipating the occurrence 1 to 4 hours in advance.

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs